Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Cutan Pathol ; 51(6): 403-406, 2024 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-38419370

RESUMO

Cutaneous pseudolymphomas are a wide group of diseases mimicking cutaneous lymphoma. They comprise several skin conditions with different etiopathogenesis, clinical-pathological features, and prognosis, which may occur in the absence of an identifiable trigger factor or after administration of medications or vaccinations, tattoos, infections, or arthropod bites. They present with different manifestations: from solitary to regionally clustered lesions, up to generalized distribution and, in rare cases, erythroderma. They persist variably, from weeks to years, and resolve spontaneously or after antibiotics, but may recur in some cases. CD30+ T-cell pseudolymphomas are characterized by the presence of large, activated lymphoid cells, generally in response to viral infections, arthropod assault reactions, and drug eruptions. Stenotrophomonas maltophilia is a ubiquitous Gram-negative bacillus responsible for opportunistic infections in immunocompromised patients. Infection of intact skin in immunocompetent patients is particularly rare. Here, we report a case of a man presenting an isolated nodule histopathologically mimicking a primary cutaneous CD30+ T-cell lymphoproliferative disorder.


Assuntos
Infecções por Bactérias Gram-Negativas , Transtornos Linfoproliferativos , Pseudolinfoma , Dermatopatias Bacterianas , Humanos , Masculino , Pessoa de Meia-Idade , Diagnóstico Diferencial , Infecções por Bactérias Gram-Negativas/diagnóstico , Infecções por Bactérias Gram-Negativas/microbiologia , Infecções por Bactérias Gram-Negativas/patologia , Imunocompetência , Antígeno Ki-1/metabolismo , Transtornos Linfoproliferativos/patologia , Transtornos Linfoproliferativos/microbiologia , Transtornos Linfoproliferativos/diagnóstico , Pseudolinfoma/patologia , Pseudolinfoma/diagnóstico , Pseudolinfoma/microbiologia , Pseudolinfoma/imunologia , Dermatopatias Bacterianas/patologia , Dermatopatias Bacterianas/diagnóstico , Dermatopatias Bacterianas/microbiologia , Dermatopatias Bacterianas/imunologia , Stenotrophomonas maltophilia/isolamento & purificação , Linfócitos T/imunologia , Linfócitos T/patologia
2.
Lupus ; 30(1): 125-133, 2021 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-33019879

RESUMO

Main subtypes of cutaneous lupus erythematosus are represented by acute, subacute cutaneous, intermittent and chronic cutaneous lupus erythematosus. Discoid lupus erythematosus represents the most common phenotype of chronic cutaneous lupus erythematosus. The spectrum of clinical manifestations mirrors that of several and distinct histopathological features. Such variability among different CLE subtypes is also observed at dermoscopy. Dermoscopy is nowadays considered an additional valuable method for skin lesions assessment in general dermatology, following and completing the well-known clinical diagnostic steps, such as medical history and clinical examination. In vivo reflectance confocal microscopy (RCM) is a non-invasive imaging tool able to assess the epidermis and upper dermis producing high resolution (horizontal ∼1.25 µm, vertical ∼5 µm), en face tissue sections used for melanocytic and inflammatory evaluation. In this study, we reported dermoscopic and RCM features about 9 patients affected by subacute and chronic lupus erythematosus retrospectively analyzed.


Assuntos
Dermoscopia/métodos , Lúpus Eritematoso Discoide/patologia , Microscopia Confocal/métodos , Adulto , Idoso , Biópsia , Feminino , Humanos , Lúpus Eritematoso Discoide/diagnóstico , Masculino , Pessoa de Meia-Idade
3.
Immunotherapy ; 12(18): 1287-1292, 2020 12.
Artigo em Inglês | MEDLINE | ID: mdl-32957824

RESUMO

Introduction: We report a case of a young female patient, previously affected by psoriatic arthritis, and treated with adalimumab, who developed a chronic spontaneous urticaria and started a concomitant therapy with omalizumab. Methods & results: A 50% reduction of the Dermatology Life Quality Index (from 7 at baseline to 4 in weeks 12 and 24) and a complete reset of the Urticaria Activity Score for 7 days (from 27 at baseline to 0 in weeks 12 and 24) were recorded. During all treatment with omalizumab, administering of adalimumab was continued. Due to complete control of urticaria symptoms, the patient stopped treatment with omalizumab after 24 weeks. Conclusion: The combination of adalimumab and omalizumab could offer a favorable efficacy and safety profile. The synergistic action of the two biological drugs in reducing systemic inflammation could be responsible for a shorter time to obtain clinical response.


Assuntos
Adalimumab/uso terapêutico , Antialérgicos/uso terapêutico , Anti-Inflamatórios/uso terapêutico , Omalizumab/uso terapêutico , Urticária/tratamento farmacológico , Adulto , Quimioterapia Combinada/métodos , Feminino , Humanos , Resultado do Tratamento , Adulto Jovem
4.
Turk Patoloji Derg ; 36(3): 251-255, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-31960941

RESUMO

Uterine leiomyomas are the most common benign tumors of the gynecological tract. Massive lymphocytic infiltration has been reported rarely in uterine leiomyomas and it has been described as a pathogenetic correlation with gonadotropin-releasing hormone agonists. Uterine leiomyomas with massive lymphoid infiltration have to be differentiated from non-Hodgkin lymphomas. We report a case of a woman without a history of gonadotropin-releasing hormone agonist treatment, who presented with a uterine leiomyoma that increased in size after the procedure of assisted in-vitro fertilization, and associated with massive nodular lymphoid infiltrate simulating, morphologically, a non-Hodgkin lymphoma. Uterine leiomyoma with massive lymphocytic infiltration is a very rare entity, probably of reactive significance, which has to be differentiated from diseases that need a systemic therapeutic approach.


Assuntos
Fertilização in vitro , Leiomioma/patologia , Neoplasias Uterinas/patologia , Adulto , Feminino , Humanos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...